P&G Buys Thorne for $3.8 Billion Premium Supplements Push

Procter & Gamble is making a significant move into the premium supplements market by acquiring Thorne, a well-respected name in science-backed health and wellness. The deal, valued at $3.8 billion, will give P&G ownership of Thorne's vertically integrated manufacturing capabilities and its reputation for high scientific standards.

The acquisition is expected to strengthen P&G's Personal Health Care business at a time when demand for self-care and preventative wellness is on the rise. Thorne has built its brand through practitioner-backed supplements, growing into a trusted name among healthcare professionals and consumers alike.

P&G believes that Thorne complements its existing health portfolio perfectly, while Thorne gains access to global scale and resources to accelerate future growth. The transaction is expected to close later this year, pending customary regulatory approvals.